Literature DB >> 27493358

Kasabach - Merritt syndrome: A case report.

Nader M Osman1.   

Abstract

Kasabach-Merritt syndrome is characterised by the combination of rapidly growing vascular tumour, thrombocytopenia, microangiopathic haemolytic anaemia and consumptive coagulopathy. The blood clotting disorder results from platelets and other clotting factors of the blood being used up within the tumor. We report a two- and- half month old Saudi female infant who presented with epistaxis, conjunctival haemorrage and bilateral periorbital ecchymosis.

Entities:  

Keywords:  Haemangioma; Hypofibrinogenemia; Kasabach-Merritt syndrome; Thrombocytopenia

Year:  2013        PMID: 27493358      PMCID: PMC4949964     

Source DB:  PubMed          Journal:  Sudan J Paediatr        ISSN: 0256-4408


  6 in total

Review 1.  Kasabach-Merritt syndrome: pathogenesis and management.

Authors:  G W Hall
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

2.  Effective therapy of a vascular tumor of infancy with vincristine.

Authors:  J Moore; M Lee; M Garzon; S Soffer; E Kim; R Saouaf; G del Toro; D Yamashiro; J Kandel
Journal:  J Pediatr Surg       Date:  2001-08       Impact factor: 2.545

Review 3.  Kasabach-merritt syndrome.

Authors:  Sheilagh Maguiness; Lyn Guenther
Journal:  J Cutan Med Surg       Date:  2002-04-15       Impact factor: 2.092

4.  Kasabach-Merritt syndrome: therapeutic considerations.

Authors:  E C Larsen; W H Zinkham; J C Eggleston; B J Zitelli
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

5.  Treatment of Kasabach-Merritt syndrome: a stepwise regimen of prednisolone, dipyridamole, and interferon.

Authors:  Siriwan Wananukul; Issaraang Nuchprayoon; Panya Seksarn
Journal:  Int J Dermatol       Date:  2003-09       Impact factor: 2.736

6.  Kasabach-Merritt syndrome with large cutaneous vascular tumors.

Authors:  Pavai Arunachalam; V R Ravi Kumar; Divya Swathi
Journal:  J Indian Assoc Pediatr Surg       Date:  2012-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.